Last week, FDA Commissioner Scott Gottlieb announced the approval of the first generic version of EpiPen, an injectable form of epinephrine used in children to treat life-threatening allergies. Under Gottlieb and HHS Secretary Alex Azar, the consistent theme is lower prices through competition.
FDA’s New Generic EpiPen Approval Exemplifies Progress on Drug Price Reform
